SCYX - Scynexis Inc
Scynexis Inc Logo

SCYX - Scynexis Inc

https://www.scynexis.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

SCYNEXIS, Inc., a biotechnology company, offers therapies for the treatment of yeast infections in the United States. The company is headquartered in Jersey City, New Jersey.

52W High
$1.66
52W Low
$0.66
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.75
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
0.91
EV/EBITDA (<8 favorable)
0.05
EV/Revenue (<3 favorable)
0.44
P/S (TTM) (<3 favorable)
11.46
P/B (<3 favorable)
0.84
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
2.09%
Institutions (25–75% balanced)
26.58%
Shares Outstanding
41,924,900
Float
37,569,400
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
3,257,000
Gross Profit (TTM)
3,257,000
EPS (TTM)
-0.40
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-7.01%
ROE (TTM) (>15% strong)
-0.37%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.85
Momentum
Bearish momentum
Value
0.0930
Previous
0.0815
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025